The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 07, 2026

Filed:

Apr. 09, 2019
Applicant:

Ohio State Innovation Foundation, Columbus, OH (US);

Inventors:

Carlos Castro, Columbus, OH (US);

Christopher Lucas, Columbus, OH (US);

Patrick Halley, Columbus, OH (US);

John Byrd, Columbus, OH (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/69 (2017.01); A61K 31/704 (2006.01); A61K 39/395 (2006.01); A61K 47/10 (2017.01); A61K 47/26 (2006.01); A61K 47/54 (2017.01); A61K 47/68 (2017.01); A61P 35/00 (2006.01); C12N 15/113 (2010.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 47/549 (2017.08); A61K 31/704 (2013.01); A61K 39/39558 (2013.01); A61K 47/10 (2013.01); A61K 47/26 (2013.01); A61K 47/6921 (2017.08); A61P 35/00 (2018.01); C12N 15/113 (2013.01); A61K 2039/505 (2013.01); A61K 2039/51 (2013.01); C12N 2310/11 (2013.01); C12N 2310/14 (2013.01); C12N 2310/141 (2013.01);
Abstract

Disclosed herein are DNA origami nanostmcture that can be functionalized for personalized and targeted drug delivery. The disclosed nanostructures enter cells through the endolysosomal pathway and circumvent drug resistance mechanisms in target cells. The disclosed nanostructures can be loaded small molecule drugs (e.g. anthracyclines, anti-metabolites) and nucleic acids (e.g. antisense oligonucleotides, siRNA, miRNA) with targeting and/or therapeutic antibodies against tumor-specific antigens (e.g. anti-CD33, anti-CD20) that can be modified to treat to a wide range of cancers and ultimately tailored to specific patients' needs for precision medicine.


Find Patent Forward Citations

Loading…